Perimenopause is the transitional phase leading up to menopause, marked by fluctuating hormone levels that can significantly affect sleep, mood, metabolism, menstrual patterns, and overall quality of life. Symptoms may begin years before menopause is officially diagnosed.
This page explains what perimenopause is, why symptoms can be unpredictable, and how LiteWell evaluates and addresses perimenopause-related concerns using a structured, physician-led, data-driven approach.
Satisfied with our services
Perimenopause is the period preceding menopause during which ovarian hormone production becomes irregular. Estrogen and progesterone levels fluctuate, sometimes dramatically, before ultimately declining.
Unlike menopause, which is defined retrospectively after 12 months without a menstrual cycle, perimenopause is characterized by variability in cycle length, symptom intensity, and hormonal patterns.
Because hormone levels fluctuate, standard lab testing may appear normal on a single measurement. Many women are told their symptoms are stress-related or age-related without deeper evaluation.
Perimenopause symptoms often overlap with thyroid dysfunction, metabolic changes, sleep disorders, and stress-related physiologic changes, requiring comprehensive clinical interpretation.
LiteWell evaluates perimenopause through a comprehensive clinical process that integrates symptom history, laboratory testing, metabolic assessment, and physician interpretation.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake when appropriate. This structured intake provides objective data to evaluate hormonal fluctuations, thyroid function, cardiometabolic health, and inflammatory markers.
– Estradiol levels (with recognition of cycle variability)
– Progesterone levels when clinically indicated
– Follicle-stimulating hormone (FSH) when appropriate
– Thyroid function panel
– Testosterone levels when relevant
– Lipid profile and cardiovascular risk markers
– Inflammatory markers such as hs-CRP
– Metabolic markers including fasting glucose and insulin
LiteWell offers physician-supervised services designed to evaluate and address perimenopause-related symptoms within a structured, individualized care pathway.
(when metabolic dysfunction is present)
For appropriate patients, LiteWell develops individualized strategies to support hormonal stability, sleep quality, metabolic health, and long-term wellness during perimenopause. When clinically indicated, physician-supervised hormone therapy may be considered.
All treatment decisions are individualized, physician-led, and guided by objective laboratory findings and careful risk assessment.
Perimenopause is the transitional phase before menopause, characterized by hormonal fluctuations and irregular cycles. Menopause is confirmed after 12 consecutive months without menstruation.
Yes. Hormone levels fluctuate significantly during perimenopause, so a single lab value may not reflect overall hormonal patterns.
Perimenopause often begins in the early to mid-40s, though some women may experience changes earlier.
Hormonal fluctuations during perimenopause can affect neurotransmitter activity and contribute to mood instability.
Changes in estrogen levels may influence fat distribution and metabolic efficiency.
For selected patients, hormone therapy may be considered after careful clinical evaluation and risk assessment.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake if appropriate.
If perimenopause symptoms are affecting daily function or quality of life, a structured medical evaluation may help clarify contributing factors and guide evidence-based next steps. LiteWell provides a physician-led approach focused on hormonal balance and long-term health optimization.
